Factors associated with delayed time to adjuvant chemotherapy in stage III colon cancer

QR Code

Factors associated with delayed time to adjuvant chemotherapy in stage III colon cancer

Background Adjuvant chemotherapy started more than 56 days after colon cancer resection has been associated with lesser overall survival among patients with stage iii colon cancer. The objective of the present population-based study was to determine, in referred patients with resected stage iii colo...

Full description

Bibliographic Details
Main Authors:	Chan, Arlene, Woods, R., Kennecke, H., Gill, S.
Format:	Journal Article
Published:	Multimed Inc. 2014
Online Access:	http://hdl.handle.net/20.500.11937/6098

Similar Items

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based Chemotherapy
by: Chan, Arlene, et al.
Published: (2013)

Utilisation of primary and secondary G-CSF prophylaxis enables maintenance of optimal dose delivery of standard adjuvant chemotherapy for early breast cancer: An analysis of 1655 patients
by: Chan, Arlene, et al.
Published: (2014)

Multidrug resistance protein 2 genetic polymorphism and colorectal cancer recurrence in patients receiving adjuvant FOLFOX-4 chemotherapy
by: Mirakhorli, Mojgan, et al.
Published: (2013)

Prevalence and management of HER2/neu-positive early breast cancer in a single institution following availability of adjuvant trastuzumab
by: Chan, Arlene, et al.
Published: (2012)

Prognostic factors associated with locoregional recurrence in colon cancer
by: Liska, David, et al.
Published: (2014)

Overexpression of activated phospholipase C?1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy
by: Lattanzio, R., et al.
Published: (2013)

Adjuvant trastuzumab in HER2-positive breast cancer.
by: Slamon, D., et al.
Published: (2011)

Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix
by: Rahman, Cheryl V., et al.
Published: (2013)

Vestibulotoxicity and balance problems associated with cisplatin chemotherapy in adult cancer survivors
by: Prayuenyong, Pattarawadee
Published: (2021)

Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epiderman growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial
by: Eiermann, W., et al.
Published: (2011)

Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens
by: Chan, Arlene, et al.
Published: (2018)

Preoperative taxane-based chemotherapy in a standardized protocol for locally advanced breast cancer
by: Chan, Arlene, et al.
Published: (2012)

Predictive Factors For Neutropenia During Chemotherapy Treatment In Breast Cancer Patients
by: Ong, Chiew Wai
Published: (2017)

Physical Activity and Colon Cancer: Timing, Intensity, and Sedentary Behavior
by: Boyle, Terry
Published: (2012)

Gut microflora: association and risk of sigmoid colon and rectal cancer
by: Mohamed Sikandar, Faizah
Published: (2015)

Applications of calixarenes in cancer chemotherapy: facts and perspectives
by: Ali, Yousaf, et al.
Published: (2015)

Curcumin combination chemotherapy: the implication and efficacy in cancer
by: Tan, Bee Ling, et al.
Published: (2019)

Accelerometer-assessed physical activity and sedentary time among colon cancer survivors: associations with psychological health outcomes
by: Vallance, J., et al.
Published: (2015)

Tumour-associated macrophages (TAMs) in colon cancer and how to reeducate them
by: Yahaya, Muhamad Afiq Faisal, et al.
Published: (2019)

Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer
by: Storr, Sarah J., et al.
Published: (2012)

Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.
by: Casciano, Fabio, et al.
Published: (2024)

Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)

Use of non anthracycline regimens in early stage breast cancer within Australia
by: De Boer, R., et al.
Published: (2011)

‘Emergency chemotherapy’ for bleeding cervical cancer: case series
by: Shafiee, MN, et al.
Published: (2012)

Cancer incidence and chemotherapy-induced adverse effects in Asia
by: Khatab, Nasir Ibrahim Omar, et al.
Published: (2019)

Associations of objectively assessed physical activity and sedentary time with health-related quality of life among colon cancer survivors
by: Vallance, J., et al.
Published: (2014)

The role of hair loss in cancer identity: perceptions of chemotherapy-induced alopecia among women treated for early-stage breast cancer or ductal carcinoma in situ
by: Trusson, Diane, et al.
Published: (2016)

Effects of cocoa polyphenol rich diet in prevention of colitis-associated colon cancer
by: Saadatdoust, Zeinab
Published: (2015)

Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study
by: Ward, R., et al.
Published: (2015)

Pharmaceutical formulations as immunological adjuvants
by: O'Hagan, Derek Thomas
Published: (1987)

Inhibiting protein–protein interactions in telomeres as an approach to cancer chemotherapy
by: Salih, Twana
Published: (2016)

Expression of survival and apoptotic molecules in response to early stage chemotherapy in acute myeloid leukaemia
by: Yiau, Stephnie Kang Xian
Published: (2013)

The ongoing effects and impact of hearing loss and tinnitus associated with platinum based chemotherapy in adults living with and beyond cancer
by: Pearson, Stephanie
Published: (2022)

Expression patterns of the human ribosomal protein genes eL14 and uS19 in colon cancer is dependent on the type and stage of the cancer cell
by: Sim, Edmund Ui-Hang, et al.
Published: (2020)

Factor causing time delay in construction Malaysia
by: Nasser Rostam, Afshar, et al.
Published: (2016)

The prevalence and factors associated with the delay in the initiation of breastfeeding
by: A. M., Mahanum, et al.
Published: (2015)

Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
by: Cameron, David, et al.
Published: (2013)

Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy
by: Ali, Yousaf, et al.
Published: (2016)

The impact on sexual functioning of chemotherapy-induced menopause in women with breast cancer.
by: Rogers, M., et al.
Published: (2002)

Cancer chemotherapy in early life significantly alters the maturation of pain processing
by: Hathway, Gareth J., et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_638fh5fg3s4nr0f8iljgs34lqh